Adenosylmethionine Disulfate Tosylate Injection 0.5?g ×?5 Vials (Baixino) – Wholesale & Laboratory Use
$1.00
Baixino Adenosylmethionine Disulfate Tosylate Injection contains 0.5?g SAMe per vial (plus solvent). Manufactured by CSPC Tianqing Pharmaceutical Group Co., Ltd., approved under NMPA H20193344. Commonly used in laboratory studies of liver protection, methylation pathways, and cholestatic liver disorders.
?? For laboratory and research use only.?Please consult staff for other specifications and uses?
描述
Adenosylmethionine (SAMe) is a key endogenous methyl donor involved in transmethylation and trans-sulfuration reactions. Its disulfate tosylate formulation is used in injectable form to protect liver cell membranes, enhance glutathione and coenzyme A synthesis, and facilitate bile flow. Widely utilized in preclinical research on cholestatic hepatitis, liver fibrosis, and metabolic liver injury.
Adenosylmethionine Disulfate Tosylate Injection Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Adenosylmethionine Disulfate Tosylate Injection (Baixino) |
| Generic Name | S-Adenosyl-L-methionine Disulfate Tosylate |
| CAS Number | 97540?22?2 |
| Molecular Formula | C??H??N?O?S·C?H?O?S·2H?SO? |
| Molecular Weight | ?766.8?g/mol |
| Dosage Form | Lyophilized powder for injection with solvent |
| Dosage per Vial | 0.5?g SAMe (as disulfate tosylate) |
| Pack Size | 5 vials + 5 vials of provided solvent |
| Approval Number | H20193344 |
| Drug Standard Code | 86901523002291 |
| Manufacturer | CSPC Tianqing Pharmaceutical Group Co., Ltd. |
| Barcode | Not yet assigned |
| Storage Conditions | Store at 2–8?°C, protected from light |
| Intended Use | Laboratory research and preclinical liver function studies |
Adenosylmethionine Disulfate Tosylate Injection Mechanism of Action
SAMe acts as a universal methyl group donor in vital biochemical pathways, supporting liver cell membrane integrity, glutathione synthesis, and bile detox pathways. It enhances cellular resilience to oxidative and cholestatic injury .
Research Application Areas
-
Models of cholestatic and drug?induced liver injury
-
Prevention of intrahepatic bile stasis and fibrosis
-
Studies of transmethylation and trans?sulfuration pathways
-
Enhancement of antioxidant defenses in hepatocytes
-
Comparative research vs. ursodeoxycholic acid in hepatic protection
Research shows SAMe improves liver tests and reduces fibrosis markers without significant adverse effects in these models ChinaGPDrugBank.
Safety & Handling
-
Adverse Effects: Rare mild gastrointestinal discomfort or sleep disturbances .
-
Reconstitution: Reconstitute each vial with supplied solvent before clinical studies.
-
Handling: Use standard lab PPE—gloves, eyewear, coat; avoid aerosol contact.
-
Storage: Maintain 2–8?°C; do not freeze; protect from light.
Core Keywords
Adenosylmethionine disulfate injection, SAMe injection, H20193344, hepatoprotective injection, liver fibrosis research, methyl donor injection, wholesale SAMe vials, lab-grade SAMe
Research Use Disclaimer
This product is strictly for laboratory and preclinical research use. It is not approved for therapeutic, diagnostic, or veterinary applications. Misuse may bear legal and health consequences. Use only under institutional protocols and regulatory oversight.
其他信息
| 重量 | 1 公斤 |
|---|---|
| 尺寸 | 26 × 23 × 26 厘米 |
相关产品
-
Compound Glycyrrhizin (Ruiyang ) – Wholesale & Retail
Compound Glycyrrhizin for Injection (Ruiyang / ???) contains 80?mg glycyrrhizin, 40?mg L?cysteine HCl, and 800?mg glycine per vial (freeze-dried powder). Produced by Ruiyang Pharmaceutical Co., Ltd., approved under NMPA H20090256. Delivered in sets of 10 vials per box. Commonly used in research and clinical support for liver protection and anti-inflammatory applications.?? For laboratory and research use only. ?Please consult staff for other specifications and uses? $1.00 -
Drotaverine Hydrochloride Injection 40?mg (No?Spa )
No?Spa Drotaverine Hydrochloride Injection delivers 40?mg per 2?ml ampoule, with five ampoules per box. Produced by CHINOIN (Hungary) and approved under NMPA HJ20170302. Ideal for laboratory research involving smooth muscle spasm relief in visceral organs and vascular systems.
?? For laboratory and research use only. ?Please consult staff for other specifications and uses? $1.00 -
Lusutrombopag Tablets 3?mg (Wenke’da / MULPLETA) – Low price wholesale
Wenke’da Lusutrombopag Tablets (MULPLETA), 3?mg per tablet, 7 tablets per blister, 1 blister per box. Produced by Quotient Sciences-Philadelphia LLC and NMPA approved under HJ20230086. Suitable for research on thrombocytopenia, platelet production, and TPO?RA mechanisms.
?? For laboratory and research use only. Not for clinical treatment.?Please consult staff for other specifications and uses? $1.00 -
Compound L?Aspartate L?Ornithine Granules 3?g (Rigan) – Wholesale & Research Use
Rigan Compound L?Aspartate L?Ornithine Granules provide 3?g per sachet, with 21 sachets per box. Manufactured by Wuhan Qirui Pharmaceutical Co., Ltd., and approved under NMPA H20090160. Designed for research into hyperammonemia, liver support, and metabolic detoxification.
?? For laboratory or research use only. ?Please consult staff for other specifications and uses? $1.00
评价
目前还没有评价